Arlington Trust’s Twist Bioscience TWST Stock Holding History

Arlington Trust’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43	Closed	-$1.58K	–	866
2023 Q4	$1.58K	Buy	+43	New	+$994	﹤0.01%	700

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arlington Trust's TWST Position: Q1 2024 in Review

Arlington Trust sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 43 shares — an estimated $1.58K sold.

Arlington Trust first reported a position in TWST in Q4 2023 and held it in 1 quarter. The position peaked at $1.58K in Q4 2023. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

Arlington Trust reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 43 Twist Bioscience shares in Q1 2024, an estimated $1.58K.
Arlington Trust first reported a position in Twist Bioscience in Q4 2023 and held it in 1 quarter.
Arlington Trust's Twist Bioscience position peaked at $1.58K in Q4 2023.
237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.